Sign in

CIK 0001010086

  • Accelerated filer

SIGA TECHNOLOGIES INC

Sign in to watch
Ticker
SIGA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
133864870
Phone
+1 212-672-9100
Business address
31 EAST 62ND STREET, NEW YORK, NY, 10065
Former names
SIGA PHARMACEUTICALS INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2013-05-15 KINDLER JEFFREY B Director Grant or award · Restricted Stock Unit +15,000 15,000
2013-05-15 CONSTANCE THOMAS E Director Grant or award · Restricted Stock Units +15,000 15,000
2013-05-15 Antal James Director Grant or award · Restricted Stock Units +15,000 15,000
2013-05-15 BAYER MICHAEL J Director Grant or award · Restricted Stock Units +15,000 15,000
2013-05-15 Bevins William C Director Grant or award · Restricted Stock Units +15,000 15,000
2013-05-15 Marshall Joseph W III Director Grant or award · Restricted Stock Units +15,000 15,000
2013-05-15 SAVAS PAUL G Director Grant or award · Restricted Stock Units +15,000 15,000
2013-05-15 SLOVIN BRUCE Director Grant or award · Restricted Stock Units +15,000 15,000
2013-05-15 TOWNSEND FRANCES F Director Grant or award · Restricted Stock Units +15,000 15,000
2013-05-15 STERN ANDREW L Director Grant or award · Restricted Stock Units +15,000 15,000
2013-05-15 WEINER MICHAEL MD Director Grant or award · Restricted Stock Units +15,000 15,000
2013-04-30 MacAndrews & Forbes Holdings Inc. Director Other acquisition · Warrant (Right to Buy) +250,000 250,000
2013-03-21 KINDLER JEFFREY B Director Grant or award · Stock Option (Right to buy) +25,000 25,000
2013-02-28 ROSE ERIC A MD Chief Executive Officer Exercise or conversion +66,666 423,301
2013-02-28 ROSE ERIC A MD Chief Executive Officer Shares withheld for taxes −27,314 $4.28 $117K 395,987
2013-02-28 ROSE ERIC A MD Chief Executive Officer Exercise or conversion · Restricted Stock Units −66,666 133,334
2013-02-28 Luckshire Daniel J Executive VP & CFO Exercise or conversion +11,666 11,666
2013-02-28 Luckshire Daniel J Executive VP & CFO Shares withheld for taxes −4,830 $4.28 $21K 6,836
2013-02-28 Luckshire Daniel J Executive VP & CFO Exercise or conversion · Restricted Stock Units +11,666 23,334
2013-02-28 Hruby Dennis E VP & Chief Scientific Officer Exercise or conversion +25,000 25,000

Page 36 of 38 · 760 trades